Diet Programs

Keto Diet For Fatty Liver / Hepatic Steatosis

Science Center

What science says about Keto Diet For Fatty Liver / Hepatic Steatosis

The keto diet for fatty liver disease has gained attention as a potential dietary approach, particularly for people with metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD). Supporters believe that restricting carbohydrates may help reduce fat accumulation in the liver by improving insulin sensitivity, promoting fat burning, and supporting weight loss.

Some clinical research has reported improvements in liver fat and metabolic markers among people following ketogenic diets. However, liver specialists and more cautious researchers point to limitations in the available evidence, particularly the lack of large, long-term clinical trials establishing whether keto can improve liver damage or prevent disease progression.

The discussion therefore centers on its potential metabolic benefits and whether these translate into lasting improvements in liver health.

 

Experts Views in Favor of the Keto Diet for Fatty Liver Disease

Supporters of the keto diet believe it may help people with fatty liver disease by addressing some of the metabolic factors that contribute to fat accumulation in the liver. Restricting carbohydrates can reduce insulin levels and encourage the body to use stored fat for energy.

This may help reduce liver fat, particularly in people who also have insulin resistance, overweight, or obesity. Weight loss can further contribute to improvements in liver health, making the diet a potential option for people whose fatty liver is associated with metabolic dysfunction.

A 2025 review titled "Ketogenic diets and metabolic dysfunction-associated steatotic liver disease: a literature review" examined research on ketogenic diets and their effects on liver health. It reported that short- to medium-term studies found improvements in hepatic steatosis and some metabolic markers, including triglyceride levels.

The review also discussed possible benefits for liver inflammation and other features of fatty liver disease. However, it noted that findings on cholesterol were mixed and that longer-term clinical trials are needed to establish the diet's benefits and risks.

Supporters also point to the potential value of very-low-calorie ketogenic diets (VLCKDs) for people with fatty liver disease who have obesity. These medically supervised programs combine substantial calorie restriction with carbohydrate restriction and can produce significant weight loss. Since losing excess weight is an important part of managing fatty liver disease, supporters consider these protocols a possible way to improve both body weight and liver-related metabolic health.

 

Experts' Views on the Limitations of the Keto Diet for Fatty Liver Disease

Despite the encouraging findings, researchers and liver specialists emphasize that improvements in body weight and metabolic markers do not necessarily translate into improvements in liver fat, inflammation, or fibrosis. They also point out that many studies examining ketogenic diets are relatively small and short-term, making it difficult to establish their long-term effectiveness and safety.

A 2025 randomized controlled trial titled "Effect of a Ketogenic Diet on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial" compared an eight-week ketogenic diet with a DASH diet education program in 24 people with MASLD. Participants following the ketogenic diet lost significantly more weight and experienced improvements in several metabolic risk factors.

However, the researchers found no significant differences between the groups in liver fat or liver stiffness measurements. They concluded that larger and longer studies were needed to determine the diet's long-term effectiveness and safety.

The 2024 joint clinical guidelines from the European Association for the Study of the Liver (EASL), the European Association for the Study of Diabetes (EASD), and the European Association for the Study of Obesity (EASO), titled "EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)," recommend sustained weight loss, dietary improvements, and regular physical activity as central parts of management.

The guidelines acknowledge that low-carbohydrate diets may help reduce liver fat, but state that there is insufficient evidence to establish the effectiveness and safety of very-low-carbohydrate ketogenic diets specifically for people with MASLD. They also highlight the Mediterranean diet for its benefits to liver fat and cardiometabolic health, as well as its potential for better long-term adherence.

Another concern is the nutritional composition of the diet. A ketogenic diet that relies heavily on saturated fats may negatively affect cholesterol levels and cardiovascular health, which is particularly relevant because fatty liver disease frequently occurs alongside other metabolic risk factors. Strict carbohydrate restriction can also be difficult to maintain over time, raising questions about long-term adherence and whether any improvements can be sustained.

 

Overall Conclusion: Does Scientific Evidence Support the Keto Diet for Fatty Liver Disease?

There is growing scientific support for the potential benefits of ketogenic diets in people with fatty liver disease, particularly through weight loss, improved insulin sensitivity, and reductions in liver fat. However, liver specialists and clinical guideline committees remain cautious about recommending strict ketogenic diets as a treatment for fatty liver disease. Their concerns center on the limited long-term evidence, inconsistent findings on liver-specific outcomes, and uncertainties about potential health risks.

In particular, it remains unclear whether the reported improvements can translate into lasting reductions in liver inflammation, fibrosis, and disease progression. Nevertheless, the main disagreement is not about the potential metabolic benefits of keto, but whether the current evidence is sufficient to establish its specific and long-term benefits for liver health. Further clinical research is needed to clarify its effectiveness, safety, and place alongside established dietary approaches.

AposBook Team
Published November 9, 2026

Views against Keto Diet For Fatty Liver / Hepatic Steatosis

No material available on this topic. You can add relevant content by using the "Add content" option. Together, we can help people and promote knowledge.

Discussion forum

Please remain authentic and respectful. Aposbook does not endorse any comment and is not responsible for any wrong information provided by users.